🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the antiretroviral activity of dora...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-05
Trial ID
NCT02403674
Treatments Being Tested
This study aims to evaluate a switch from fixed dose combination (FDC) trea...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-04
Trial ID
NCT02652260
Transgender women living with Human Immunodeficiency Virus (HIV) may priori...
Status
Completed
Location
Clinical Research Unit at Thomas Jefferson University
Start Date
2022-01-04
Trial ID
NCT04283656
Treatments Being Tested
This is a study to evaluate the safety, tolerability, pharmacokinetics, and...
Status
Completed
Location
Multiple Locations
Start Date
2011-10-21
Trial ID
NCT01466985
Treatments Being Tested
This study will evaluate the safety and efficacy of a switch to Doravirine/...
Status
Completed
Location
Pueblo Family Physicians ( Site 2717)
Start Date
2020-02-18
Trial ID
NCT04223791
Treatments Being Tested
This is a randomized, active-controlled, double-blind clinical study design...
Status
Active Not Recruiting
Location
Pueblo Family Physicians ( Site 5674)
Start Date
2023-03-08
Trial ID
NCT05705349
Treatments Being Tested
The hypothesis tested in this study is that doravirine (MK-1439) at the fin...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-12
Trial ID
NCT01632345
Treatments Being Tested
The primary objectives of this study are to evaluate the antiretroviral act...
Status
Active Not Recruiting
Location
Pueblo Family Physicians ( Site 1425)
Start Date
2023-02-17
Trial ID
NCT05630755
Treatments Being Tested
This study will evaluate the safety, tolerability, antiretroviral activity,...
Status
Completed
Location
Pueblo Family Physicians ( Site 0119)
Start Date
2017-11-27
Trial ID
NCT03272347
This is a phase 3, randomized, controlled, double-blind, multisite clinical...
Status
Completed
Location
University of Alabama at Birmingham 1917 Research Clinic ( Site 5610)
Start Date
2020-02-28
Trial ID
NCT04233879
Treatments Being Tested